Magazine · Issue 01 · Made in Europe
The latest approvals in Europe
Between March and September, Europe cleared 41 new medicines and a new class of AI-driven diagnostics. European companies led just over half, yet the first-of-their-kind treatments still belong mostly to rare diseases and specialist cancers.
